42 CFR Ch. IV (10–1–12 Edition) § 410.35
§ 410.35 42 CFR Ch. IV (10–1–12 Edition) the last screening mammography was (1) Colorectal cancer screening tests performed. means any of the following procedures furnished to an individual for the pur- [59 FR 49833, Sept. 30, 1994, as amended at 60 FR 14224, Mar. 16, 1995; 60 FR 63176, Dec. 8, pose of early detection of colorectal 1995; 62 FR 59100, Oct. 31, 1997; 63 FR 4596, cancer: Jan. 30, 1998] (i) Screening fecal-occult blood tests. (ii) Screening flexible § 410.35 X-ray therapy and other radi- sigmoidoscopies. ation therapy services: Scope. (iii) In the case of an individual at Medicare Part B pays for X-ray ther- high risk for colorectal cancer, screen- apy and other radiation therapy serv- ing colonoscopies. ices, including radium therapy and ra- (iv) Screening barium enemas. dioactive isotope therapy, and mate- (v) Other tests or procedures estab- rials and the services of technicians ad- lished by a national coverage deter- ministering the treatment. mination, and modifications to tests [51 FR 41339, Nov. 14, 1986. Redesignated at 55 under this paragraph, with such fre- FR 53522, Dec. 31, 1990] quency and payment limits as CMS de- termines appropriate, in consultation § 410.36 Medical supplies, appliances, with appropriate organizations and devices: Scope. (2) Screening fecal-occult blood test (a) Medicare Part B pays for the fol- means— lowing medical supplies, appliances (i) A guaiac-based test for peroxidase and devices: activity, testing two samples from (1) Surgical dressings, and splints, each of three consecutive stools, or, casts, and other devices used for reduc- (ii) Other tests as determined by the tion of fractures and dislocations.
[Show full text]